Prime Medicine revenue was $4.63M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $838.0k, down 31.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PRME annual revenue was $4.6M, with 55.3% growth year-over-year.
PRME past revenue growth
How has PRME's revenue growth performed historically?
Prime Medicine (NASDAQ: PRME) reported Q4 2025 revenue of $838.00 thousand up 61.61% year over year. In the same quarter last year, Prime Medicine's revenue was $2.18 million.
What was Prime Medicine's revenue in 2025?
Prime Medicine's annual revenue for the twelve months ending Dec 31, 2025 was $4.63 million, a 55.28% increase year over year.
How much does Prime Medicine make in a day?
Based on Prime Medicine annual revenue for the past five years, PRME makes an average of $4,172.60 per day.
What was Prime Medicine's annual revenue growth in the past year?
As of Q1 2026, Prime Medicine's revenue has grown 55.28% year over year. This is 370.68 percentage points lower than the US Biotechnology industry revenue growth rate of 425.96%. Prime Medicine's revenue in the past year totaled $4.63 million.
How much does Prime Medicine make in a year?
Prime Medicine's revenue by year for the past five years is:
Prime Medicine's revenue for the twelve months ending Dec 31, 2025 was $4.63 million, a 55.28% increase year over year.
Prime Medicine's annual revenue for Dec 31, 2024 was $2.98 million, a Infinity% increase from 2023.
Prime Medicine's annual revenue for 2023 was $0.00, a N/A decrease from 2022.
Prime Medicine's annual revenue for 2022 was $0.00, a N/A decrease from 2021.
Prime Medicine's annual revenue for 2021 was $0.00, a 100% decrease from 2020.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.